Designing immunoconjugates for cancer therapy

Author： Govindan Serengulam V   Goldenberg David M  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.12, Iss.7, 2012-07, pp. : 873-890

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eukaryotic expression vectors and immunoconjugates for cancer therapy

By Glinka E.   Edelweiss E.   Deyev S.  

Biochemistry (Moscow), Vol. 71, Iss. 6, 2006-06 ,pp. : 597-606

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Tumour-targeted chemotherapy with immunoconjugates of calicheamicin

By Damle Nitin K  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 9, 2004-09 ,pp. : 1445-1452

Informa Healthcare

Access to resources Recommend Favorite

Antiprotease therapy in cancer: hot or not?

By Lah Tamara T   Durán Alonso María Beatriz   Van Noorden Cornelis JF  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 3, 2006-03 ,pp. : 257-279

Informa Healthcare

Access to resources Recommend Favorite

Recombinant immunotoxins for cancer therapy

By Brinkmann Ulrich   Keppler-Hafkemeyer Andrea   Hafkemeyer Peter  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 4, 2001-07 ,pp. : 693-702

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for colorectal cancer

By Kerr DJ   Seymour LW   Maruta F  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 5, 2003-08 ,pp. : 779-788

Informa Healthcare

Access to resources Recommend Favorite